Back
Ligand Pharmaceuticals Stock Price Chart

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
48
LGND
Ligand Pharmaceuticals
Last Price:
$107.04
Seasonality Move:
7.17%
7 Day Trial
ALL ACCESS PASS
$
7

Mode Mobile Could be Next in Line
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and LGND is experiencing buying pressure, which is a positive indicator for future bullish movement.
Ligand Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 101.85 | Buy |
20-day SMA: | 105.6 | Buy |
50-day SMA: | 111.37 | Sell |
200-day SMA: | 107.82 | Sell |
8-day EMA: | 103.61 | Buy |
20-day EMA: | 105.47 | Buy |
50-day EMA: | 109.08 | Sell |
200-day EMA: | 105.22 | Buy |
Ligand Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.41 | Sell |
Relative Strength Index (14 RSI): | 50.08 | Buy |
Chaikin Money Flow: | 82217 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (102.28 - 109.54) | Buy |
Bollinger Bands (100): | (107.12 - 119.32) | Sell |
Ligand Pharmaceuticals Technical Analysis
Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Ligand Pharmaceuticals Stock
Is Ligand Pharmaceuticals Stock a Buy?
-
Ligand Pharmaceuticals share price is 106.59 while LGND 8-day simple moving average is 101.85, which is a Buy signal.
-
The stock price of LGND is 106.59 while Ligand Pharmaceuticals 20-day SMA is 105.60, which makes it a Buy.
-
Ligand Pharmaceuticals 50-day simple moving average is 111.37 while LGND share price is 106.59, making it a Sell technically.
-
LGND stock price is 106.59 and Ligand Pharmaceuticals 200-day simple moving average is 107.82, creating a Sell signal.
LGND Technical Analysis vs Fundamental Analysis
Sell
48
Ligand Pharmaceuticals (LGND)
is a Sell
Is Ligand Pharmaceuticals a Buy or a Sell?
-
Ligand Pharmaceuticals stock is rated a SellThe current Ligand Pharmaceuticals [LGND] share price is $106.59. The Score for LGND is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Ligand Pharmaceuticals Stock Info
Market Cap:
2.1B
Price in USD:
106.59
Share Volume:
114.2K
Ligand Pharmaceuticals 52-Week Range
52-Week High:
129.90
52-Week Low:
67.72
Sell
48
Ligand Pharmaceuticals (LGND)
is a Sell
Ligand Pharmaceuticals Share Price Forecast
-
What is the Ligand Pharmaceuticals stock price today?The Ligand Pharmaceuticals stock price is 106.59 USD today.
-
Will LGND stock go up or go down?Ligand Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Ligand Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ligand Pharmaceuticals is overvalued.
Is Ligand Pharmaceuticals Stock a Buy?
-
Ligand Pharmaceuticals share price is 106.59 while LGND 8-day exponential moving average is 103.61, which is a Buy signal.
-
The stock price of LGND is 106.59 while Ligand Pharmaceuticals 20-day EMA is 105.47, which makes it a Buy.
-
Ligand Pharmaceuticals 50-day exponential moving average is 109.08 while LGND share price is 106.59, making it a Sell technically.
-
LGND stock price is 106.59 and Ligand Pharmaceuticals 200-day simple moving average is 105.22, creating a Buy signal.
Fundamental Analysis of Ligand Pharmaceuticals
Is Ligand Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.33 per share, an increase this year of $0.45 per share, and an increase next year of $0.84 per share.
Technical Analysis of Ligand Pharmaceuticals
Should I short Ligand Pharmaceuticals stock?
-
LGND Moving Average Covergence Divergence (MACD) indicator is -2.41, suggesting Ligand Pharmaceuticals is a Sell
-
Ligand Pharmaceuticals Relative Strength Index (RSI) is 50.08, which suggest Ligand Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Ligand Pharmaceuticals is (102.28 - 109.54), which suggest Ligand Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Ligand Pharmaceuticals is (107.12 - 119.32), which suggest Ligand Pharmaceuticals is a Sell
* Ligand Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.